Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 20/20 | 0.85 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.85 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.85 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.85 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.85 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.85 |
| ▸ | MAPKAPK3 | Q16644 | 1/20 | 0.85 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4535215 | 0.92 | HDAC1 (1.00) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL4539214 | 0.92 | HDAC1 (1.00) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL24890904 | 0.88 | HDAC1 (0.74) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL24890601 | 0.88 | HDAC1 (0.74) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL24890711 | 0.88 | HDAC1 (0.74) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL24890484 | 0.88 | HDAC1 (0.74) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL4534462 | 0.83 | HDAC1 (1.00) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL4532572 | 0.82 | HDAC1 (0.81) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL4536260 | 0.82 | HDAC1 (1.00) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 | |
| SCHEMBL4540246 | 0.81 | HDAC1 (0.83) | HDAC1HDAC2HDAC3CYP2C9SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023284651-A1 | N-(2-AMINOPHENYL)BENZAMIDE COMPOUND AND APPLICATION THEREOF | 南京明德新药研发有限公司 | 2023-01-19 | — | — | WO | disclosed |